China Biotech Services Holdings (SEHK:8037) Balance Sheet Analysis 2005-2025

Socials

NEWSLETTER

View Data Providers

NEWSLETTER

View Data Providers

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

Metric	2023	2024	LTM
Total Cash And Short-Term Investments	HK$72.087M	HK$18.913M	HK$11.29M
Net Receivables	HK$19.764M	HK$21.045M	HK$7.988M
Inventory	HK$9.274M	HK$3.971M	HK$2.55M
Prepaid Expenses And Other Current Assets	HK$5.829M	HK$4.357M	-
Other Current Assets	HK$154.212M	HK$14.809M	HK$14M
Total Current Assets	HK$261.166M	HK$63.095M	HK$35.828M
Property, Plant And Equipment	HK$124.215M	HK$235.337M	HK$265.098M
Goodwill And Intangible Assets	HK$164.825M	HK$138.838M	HK$139.238M
Long-Term Investments	HK$56.92M	HK$43.229M	HK$43.703M
Deferred Tax Assets	-	-	-
Other Noncurrent Assets	HK$55.236M	HK$49.456M	HK$54.559M
Total Noncurrent Assets	HK$401.196M	HK$466.86M	HK$502.598M
Other Assets	-	-	-
Total Assets	HK$662.362M	HK$529.955M	HK$538.426M

Metric	2023	2024	LTM
Total Payables	HK$9.517M	HK$25.871M	HK$8.098M
Accrued Expenses	HK$23.1M	HK$20.353M	-
Short-Term Debt	HK$84.84M	HK$138.693M	HK$139.179M
Current Portion Of Lease Obligations	HK$9.829M	HK$5.711M	HK$4.391M
Income Taxes Payable	HK$3.73M	HK$0.117M	-
Current Deferred Revenue	-	-	-
Other Current Liabilities	HK$32.181M	HK$20.504M	HK$44.023M
Total Current Liabilities	HK$159.467M	HK$192.614M	HK$195.691M
Long-Term Debt	HK$-5.727M	HK$39.842M	HK$59.809M
Capital Lease Obligations	HK$15.556M	HK$7.504M	HK$9.418M
Noncurrent Deferred Revenue	-	-	-
Noncurrent Deferred Tax Liabilities	HK$6.442M	HK$5.043M	-
Other Noncurrent Liabilities	-	HK$46.482M	HK$60.986M
Total Noncurrent Liabilities	HK$12.169M	HK$94.953M	HK$130.849M
Other Liabilities	-	-	-
Total Liabilities	HK$171.636M	HK$287.567M	HK$326.54M

Metric	2023	2024	LTM
Treasury Stock	-	-	-
Preferred Stock	-	-	-
Common Stock	HK$96.323M	HK$97.573M	HK$97.573M
Retained Earnings	HK$-310.798M	HK$-534.467M	-
Additional Paid-In Capital	HK$490.692M	HK$494.182M	-
Accumulated Other Comprehensive Income	HK$186.537M	HK$207.654M	HK$141.358M
Other Stockholders' Equity	-	-	-
Total Common Stockholders' Equity	HK$462.754M	HK$264.942M	HK$238.931M
Minority Interest	HK$27.972M	HK$-22.554M	HK$-27.045M
Total Equity	HK$490.726M	HK$242.388M	HK$211.886M
Total Liabilities And Equity	HK$662.362M	HK$529.955M	HK$538.426M

Metric	2023	2024	LTM
Total Investments	HK$56.92M	HK$43.229M	HK$43.703M
Total Debt	HK$100.396M	HK$187.832M	HK$213.433M
Net Debt	HK$28.309M	HK$168.919M	HK$202.143M

China Biotech Services Holdings
8037

Balance Sheet

Balance Sheet Composition

China Biotech Services Holdings 8037

Balance Sheet

Balance Sheet Composition

China Biotech Services Holdings
8037